Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
209.32
+3.97 (1.93%)
Feb 11, 2026, 4:00 PM EST - Market closed
Quest Diagnostics Revenue
In the year 2025, Quest Diagnostics had annual revenue of $11.04B with 11.78% growth. Quest Diagnostics had revenue of $2.81B in the quarter ending December 31, 2025, with 7.06% growth.
Revenue (ttm)
$11.04B
Revenue Growth
+11.78%
P/S Ratio
2.11
Revenue / Employee
$197,054
Employees
56,000
Market Cap
23.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.04B | 1.16B | 11.78% |
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
| Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.77B |
| Agilent Technologies | 6.95B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
| Waters | 3.17B |
| Exact Sciences | 3.08B |
| Revvity | 2.86B |
DGX News
- 1 day ago - Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand - Reuters
- 1 day ago - Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share - PRNewsWire
- 1 day ago - Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization - PRNewsWire
- 1 day ago - The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports - Seeking Alpha
- 9 days ago - Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease - PRNewsWire
- 14 days ago - Quest Diagnostics: A Continuing Bullish Case For A Leader Among Diagnostic Testing Brands - Seeking Alpha
- 21 days ago - Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year - PRNewsWire